Literature DB >> 6690884

Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms.

M D Fallon, S L Teitelbaum, R S Weinstein, S Goldfischer, D M Brown, M P Whyte.   

Abstract

Histochemical and direct enzyme analysis of osseous tissue from 23 patients with hypophosphatasia revealed that all clinical forms of this inherited metabolic bone disease are characterized by deficiency of alkaline phosphatase (ALP) activity in bone. The severe infantile form has the most profound deficiency, infantile form has the most profound deficiency, yet the cellular source of this enzyme--osteoblasts and their matrix vesicles--are normal by routine light and electron microscopy. Despite radiographic changes in bone metaphyses consistent with rickets, iliac crest biopsy of one affected child revealed no abnormalities; the other had evidence of a mineralization defect, but not as severe as that in affected infants. In this child and several affected adults with osteomalacia, osteoblasts appeared flat and metabolically inactive. Although these histological changes suggested a different pathogenetic mechanism for adult and childhood hypophosphatasia, these changes are most likely secondary to the underlying osteomalacia. Our findings are most consistent with evidence that childhood and adult hypophosphatasia often represent clinical expression of the heterozygous state for ALP deficiency which, when homozygous, results in the clinically severe, recessive, infantile form. Histochemical and direct analysis of bone tissue from controls and patients with hypophosphatasia demonstrated that the severe infantile form is associated with the most severe ALP deficiency. In the milder clinical forms, ALP deficiency in bone is not as profound. In general, the severity of the clinical expression of hypophosphatasia reflects the magnitude of the deficiency of ALP in bone. This is the expected finding for this inborn error of metabolism, which illustrates the major role bone ALP activity has in the process of normal skeletal mineralization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690884

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  19 in total

1.  Skeletal mineralization defects in adult hypophosphatasia--a clinical and histological analysis.

Authors:  F Barvencik; F Timo Beil; M Gebauer; B Busse; T Koehne; S Seitz; J Zustin; P Pogoda; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2011-01-26       Impact factor: 4.507

2.  Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia.

Authors:  K N Fedde; L Blair; J Silverstein; S P Coburn; L M Ryan; R S Weinstein; K Waymire; S Narisawa; J L Millán; G R MacGregor; M P Whyte
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

3.  Hypophosphatasia - pathophysiology and treatment.

Authors:  José Luis Millán; Horacio Plotkin
Journal:  Actual osteol       Date:  2012-09-01

Review 4.  Hypophosphatasia: clinical manifestation and burden of disease in adult patients.

Authors:  Francesco Conti; Lorenzo Ciullini; Giuseppe Pugliese
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

5.  Causes of increased renal medullary echogenicity in Turkish children.

Authors:  A Nayir; A Kadioğlu; A Sirin; S Emre; E Tonguç; I Bilge
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

6.  Case report: premature exfoliation of primary teeth in a 4-year-old child, a diagnostic dilemma.

Authors:  G Sharma; R Whatling
Journal:  Eur Arch Paediatr Dent       Date:  2011-12

Review 7.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

8.  Dose response of bone-targeted enzyme replacement for murine hypophosphatasia.

Authors:  Manisha C Yadav; Isabelle Lemire; Pierre Leonard; Guy Boileau; Laurent Blond; Martin Beliveau; Esther Cory; Robert L Sah; Michael P Whyte; Philippe Crine; José Luis Millán
Journal:  Bone       Date:  2011-03-31       Impact factor: 4.398

9.  Hypophosphatasia may lead to bone fragility: don't miss it.

Authors:  Pierre Moulin; Frédéric Vaysse; Eric Bieth; Etienne Mornet; Isabelle Gennero; Sara Dalicieux-Laurencin; Christiane Baunin; Marie Thérèse Tauber; Jérôme Sales De Gauzy; Jean Pierre Salles
Journal:  Eur J Pediatr       Date:  2008-09-26       Impact factor: 3.183

10.  Prosthetic rehabilitation of hypophosphatasia: a case report.

Authors:  Bora Bağiş; Esra Baltacioğlu; Elif Aydoğan; Evşen Tamam
Journal:  Cases J       Date:  2008-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.